Susquehanna International Group
TRAW icon

Susquehanna International Group’s Traws Pharma TRAW Stock Holding History

Susquehanna International Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,197
Closed -$16K – 14308
2025
Q4 		$16K Buy
+14,197
New +$31.6K ﹤0.01% 12000
2023
Q4 		– Sell
-1,229
Closed -$22.2K – 13445
2023
Q3 		$22.2K Buy
+1,229
New +$28K ﹤0.01% 11576
2023
Q2 		– Sell
-1,136
Closed -$20.7K – 13321
2023
Q1 		$20.7K Buy
+1,136
New +$24.6K ﹤0.01% 12041
2022
Q3 		– Sell
-534
Closed -$18K – 14273
2022
Q2 		$18K Buy
+534
New +$18K ﹤0.01% 12392
2021
Q4 		– Sell
-1,214
Closed -$97.6K – 14045
2021
Q3 		$116K Buy
+1,214
New +$156K ﹤0.01% 11974
2021
Q2 		– Sell
-1,061
Closed -$397K – 13381
2021
Q1 		$397K Buy
+1,061
New +$400K ﹤0.01% 10003
2020
Q4 		– Sell
-139
Closed -$15K – 11834
2020
Q3 		$15K Buy
139
+62
+81% +$15.3K ﹤0.01% 10397
2020
Q2 		$16K Sell
77
-2,889
-97% -$441K ﹤0.01% 9945
2020
Q1 		$337K Buy
+2,966
New +$466K ﹤0.01% 7755
2018
Q3 		– Sell
-5
Closed -$12K – 10392
2018
Q2 		$12K Buy
+5
New +$14.5K ﹤0.01% 9460

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's TRAW Position: Q1 2026 in Review

Susquehanna International Group sold out of Traws Pharma (TRAW) in Q1 2026, closing a stake of 14,197 shares — an estimated $16K sold.

Susquehanna International Group first reported a position in TRAW in Q2 2018 and held it in 10 quarters. The position peaked at $397K in Q1 2021. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Susquehanna International Group reported no remaining Traws Pharma position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 14,197 Traws Pharma shares in Q1 2026, an estimated $16K.
  • Susquehanna International Group first reported a position in Traws Pharma in Q2 2018 and held it in 10 quarters.
  • Susquehanna International Group's Traws Pharma position peaked at $397K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.